The Risk of Post-menopausal Breast Cancer After Estrogen and Estrogen-Progestin Replacement

  • C. Magnusson
  • I. R. Persson
  • E. Weiderpass
  • N. Correia
Conference paper

Summary

Hormone replacement therapy (HRT) in post-menopausal women is widely used for symptom relief and disease prevention. As sex hormones are involved in the etiology of breast cancer (BC), there is concern that hormone substitution after the menopause may increase BC risk. Accumulated epidemiological evidence shows that many years of recent or current HRT use leads to moderate excess risk of early stage BC, particularly in non-obese women. Results from our recently completed population-based study, including 3,345 cases of BC and 3,454 controls, aged 50–74 years, reveal clear and strong relationships between long-term intake of both estrogens (Es) and Es combined with progestins, seemingly confined to women with normal or lean body build. The results also suggest that the duration-dependent excess risk remains a long time after treatment cessation and that continuously/combined E-progestin treatment may be more adverse than those cyclically/combined. Our observations raise additional concern about the long-term safety of HRT and call for research efforts to define the safest possible HRT- regimens.

Keywords

Estrogen Osteoporosis Oncol Estradiol Progestin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Key TJ, Pike MC (1988) The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 24:29–43.PubMedCrossRefGoogle Scholar
  2. 2.
    Pike MC, Spicer DV, Dahmoush L et al. (1993) Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15:17–35.PubMedGoogle Scholar
  3. 3.
    Collaborative Group on Hormonal Factors in Breast Cancer Breast cancer and hormone replacement therapy (1997) Collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 10 8411 women without breast cancer. Lancet 350:1047–1059.CrossRefGoogle Scholar
  4. 4.
    Magnusson CM, Persson IR, Baron JA et al. (1998) The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50–74 years. Int J Cancer 80:231–236.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 2001

Authors and Affiliations

  • C. Magnusson
  • I. R. Persson
  • E. Weiderpass
  • N. Correia

There are no affiliations available

Personalised recommendations